Navigation Links
Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
Date:4/16/2009

First Quarter 2009 Financial Results

VANCOUVER, April 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the first quarter ended March 31, 2009, on Thursday April 30, 2009 at 11:00 AM ET (8:00 AM Pacific).

    Dial-in information for the earnings call on April 30, 2009 is as
    follows:
    North America (toll-free): (800) 901-5247
    International: (617) 786-4501
    Enter Passcode: 72734002

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the call on April 30 at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until May 7, 2009.

    Replay information is as follows:
    North America (toll-free): (888) 286-8010
    International: (617) 801-6888
    Enter Passcode: 95526962

    About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
2. Angiotech announces positive results from Bio-Seal(TM) clinical study
3. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
4. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
5. Angiotech Pharmaceuticals announces time change of conference call and webcast
6. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
7. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
8. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
9. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
10. Angiotech wins before the UK House of Lords
11. Angiotech to Establish Separate Operating and Royalty Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Peter Walter was chosen ... for his pioneering work on how proteins are transported ... a regulatory mechanism that cells use to handle stress ... is a professor of biochemistry at the University of ... treating a range of human diseases related to defective ...
(Date:3/27/2015)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... platform company serving the global pharmaceutical, biotechnology, and ... New Drug (IND) application for WuXi MedImmune,s novel ... accepted for review by the China Food and ... 2012, MedImmune, the global biologics research and development ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 Governor ... 2015 application period for 43North - the world’s largest ... including a grand prize of $1 million, six $500,000 ... from around the world to compete for prizes that ... enterprises in the Western New York region. , ...
(Date:3/26/2015)... 26, 2015 PRC Clinical, a Silicon-Valley ... several management and executive appointments effective immediately. , Mike ... (CFO) and member of the Board of Directors. Daniel ... and Sue Dowden will assume the position of Senior ... Chief Operations Officer (COO), has been appointed to the ...
Breaking Biology Technology:German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3
... 2012  Discovery Laboratories, Inc. (NASDAQ: DSCO ) ... demonstrating that the lower rate of reintubation previously reported ... with infants treated with Curosurf ® and Survanta ... resulted in a potential hospital cost savings of $160,000 ...
... microscope in the hope of reducing the time taken to diagnose ... and 1 cm wide at its tip, could be used by ... guidance tool; dentists could also use it to screen for early-stage ... April, in IOP Publishing,s Journal of Micromechanics and Microengineering , ...
...   AMRI (NASDAQ: AMRI ) ... its research and contract manufacturing services on the ... industries. AMRI SMARTSOURCING™ is a series of strategic ... outcomes. SMARTSOURCING™ is based on 21 years of ...
Cached Biology Technology:Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 2Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 3Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 4Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 5Handheld probe shows great promise for oral cancer detection 2AMRI Launches SMARTSOURCING™ For Contract Manufacturing and Research Services 2
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces its ... of the products featured in 2015 "I Want That" ... PM EST on the DIY Network.   ... Vegas , site of the 2015 International CES ...
(Date:3/17/2015)... , March 17, 2015 Emotient, the ... software, today announced general availability of Emotient ... for the analysis of facial expressions. The system ... media content, products and services. It delivers audience ... and sentiment - as derived from facial evidence ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... Innovation in New Zealand have developed a new chemical approach ... treat Alzheimer,s disease. The team used a ... heparan sulphates, which are known to control the formation of ... Heparan sulphates are found in nearly every cell of the ...
... in one of Western Europe,s largest lakes, Lake Geneva, in ... ocean have shown that these small bits of plastic can ... or other small waterborne organisms, the full extent of their ... The study, which is being extending under a mandate by ...
... 2013 /PRNewswire-iReach/ -- The National Association of Specialty ... joined the association as a Founding Corporate Member. ... the industry including specialty pharmacies, pharmaceuticals companies, health ... "We are honored and excited to ...
Cached Biology News:New chemical approach to treat Alzheimer's 2Microplastic pollution prevalent in lakes too 2Microplastic pollution prevalent in lakes too 3CARE Pharmacies Joins National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member 2
Porcine Aortic Smooth Muscle Cells (PAOSMC) (>500,000 cells)...
... Recognizes an epitope located in ... isotype IV. No reactivity with ... ascites fluid synthetic peptide corresponding ... β-tubulin isotype IV, conjugated to ...
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
Biology Products: